|
|
||||||||||||||||||
|
|
||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionThe eBioMM17F3 antibody is a mouse IgG1 immunoglobulin which reacts with mouse IL-17A. The eBioMM17F3 antibody is a neutralizing antibody. The eBioMM17F3 antibody has been tested by indirect ELISA against mouse IL-17B, IL-17C, IL-17D, IL-17E, and IL-17F, and has been found not to react to these other IL-17 family members. Interleukin-17A (IL-17A) is a CD4+ T cell-derived cytokine that promotes inflammatory responses in cell lines and is elevated in rheumatoid arthritis, asthma, multiple sclerosis, psoriasis, and transplant rejection. The cDNA encoding human IL-17A was isolated from a library of CD4+ T cells; the encoded protein exhibits 72 percent amino acid identity with HVS13 , an open reading frame from a T lymphotropic Herpesvirus saimiri, and 63 percent with mouse CTLA-8 (cytotoxic T-lymphocyte associated antigen-8). Human IL-17A exists as glycosylated 20-30 kD homodimers. High levels of IL-17A homodimer are produced by activated peripheral blood CD4+ T-cells. IL-17A enhances expression of the intracellular adhesion molecule-1 (ICAM-1) in human fibroblasts. Human IL-17A also stimulates epithelial, endothelial, or fibroblastic cells to secrete IL-6, IL-8, G-CSF, and PGE2. In the presence of human IL-17A fibroblasts can sustain the proliferation of CD34+ hematopoietic progenitors and induce maturation into neutrophils. Mouse, rat, and human IL-17A can induce IL-6 secretion in mouse stromal cells, indicating that all homologs can recognize the mouse IL-17A receptor. IL-23-dependent, IL-17A-producing CD4+ T cells (Th-17 cells) have been identified as a unique subset of Th cells that develops along a pathway that is distinct from the Th1- and Th2- cell differentiation pathways. The hallmark effector molecules of Th1 and Th2 cells, e.g., IFN-γ and IL-4, have each been found to negatively regulate the generation of these Th-17 cells. Applications ReportedFor research use only, not for diagnostic or therapeutic use. The eBioMM17F3 antibody has been reported useful for neutralization of mouse IL-17A bioactivity and for intracellular staining of IL-17A-producing cells (IC Flow). Applications TestedThe Functional Grade Purified eBioMM17F3 antibody has been tested by LAL assay to verify low endotoxin level and has been tested for neutralization of IL-17A bioactivity. For in vitro neutralization, the Functional Grade purified eBioMM17F3 antibody at 8.0 ng/ml has been found to neutralize by 50% the biological effect of 5.0 ng/ml mouse IL-17A in an assay of IL-6 secretion by NIH/3T3 cells. Detailed information and protocols about cytokine bioassays and in vitro cytokine neutralization using antibodies can be found in the BestProtocols section. References
Uyttenhove, C., and J. Van Snick. 2006. Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur J Immunol. 36: 2868-74 Related ProductsCat. 16-4714 Functional Grade Purified Mouse IgG1, K Isotype Control Cat. 16-7178 Functional Grade Purified anti-human IL-17A (Interleukin-17A, IL17A) (clone eBio64CAP17) Cat. 16-7232 Functional Grade Purified anti-mouse IL-23 (Interleukin-23, IL23) p19 (clone G23-8) Cat. 88-7234 Mouse IL-23 (p19/p40, IL23) ELISA Ready-SET-Go! Cat. 88-7344 Human/ Mouse TGFb1 (Transforming Growth Factor beta 1, TGF-beta1, TGF-b1) ELISA Ready-SET-Go! Cat. 34-8061 Carrier-Free Recombinant Mouse IL-6 (Interleukin-6, IL6) Cat. 14-8171 Recombinant Mouse IL-17A (Interleukin-17A, IL17A) Cat. 34-8171 Carrier-Free Recombinant Mouse IL-17A (Interleukin-17A, IL17A) Cat. 34-8231 Carrier-Free Recombinant Mouse IL-23 (Interleukin-23, IL23) Cat. 34-8348 Carrier-Free Recombinant Human TGFb1 (Transforming Growth Factor beta 1, TGF-beta1, TGF-b1) |
||||||||||||||||||||||||||||||||||||||
![]() |
![]() |
|
Copyright © 2000-2008 eBioscience, Inc. Product For Research Use Only: Not for further distribution without written consent. |